Sansure Biotech Balance Sheet Health
Financial Health criteria checks 5/6
Sansure Biotech has a total shareholder equity of CN¥7.4B and total debt of CN¥20.4M, which brings its debt-to-equity ratio to 0.3%. Its total assets and total liabilities are CN¥8.3B and CN¥878.7M respectively. Sansure Biotech's EBIT is CN¥447.2M making its interest coverage ratio -1.6. It has cash and short-term investments of CN¥4.8B.
Key information
0.3%
Debt to equity ratio
CN¥20.41m
Debt
Interest coverage ratio | -1.6x |
Cash | CN¥4.81b |
Equity | CN¥7.43b |
Total liabilities | CN¥878.68m |
Total assets | CN¥8.31b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 688289's short term assets (CN¥6.1B) exceed its short term liabilities (CN¥771.8M).
Long Term Liabilities: 688289's short term assets (CN¥6.1B) exceed its long term liabilities (CN¥106.9M).
Debt to Equity History and Analysis
Debt Level: 688289 has more cash than its total debt.
Reducing Debt: 688289's debt to equity ratio has increased from 0% to 0.3% over the past 5 years.
Debt Coverage: 688289's debt is well covered by operating cash flow (5691.4%).
Interest Coverage: 688289 earns more interest than it pays, so coverage of interest payments is not a concern.